ZEVENBERGEN CAPITAL INVESTMENTS LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1276918
EDMONDS, WA
Position in ARQT
as of Mar 31, 2026
· filed Apr 9, 2026
Position Value
$8,422,464
-$3,717,272 QoQ
Shares Held
357,490
-14.5% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 75.52798679683347.ToString("F0")%
Shared 0.ToString("F0")%
None 24.472013203166522.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ZEVENBERGEN CAPITAL INVESTMENTS LLC holds $19,333,430 across 2 Biotechnology names. ARQT ranks #2 (43.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
610,233 | $10,910,966 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
357,490 | $8,422,464 |
All Filings in ARQT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,422,464 | 357,490 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $12,139,736 | 418,035 | Shares | Sole | 2026-01-15 | |
| No filing history on record for this holder in this stock. | ||||||